Correlation Between Procter Gamble and Bristol-Myers Squibb

Can any of the company-specific risk be diversified away by investing in both Procter Gamble and Bristol-Myers Squibb at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procter Gamble and Bristol-Myers Squibb into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Procter Gamble and Bristol Myers Squibb, you can compare the effects of market volatilities on Procter Gamble and Bristol-Myers Squibb and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procter Gamble with a short position of Bristol-Myers Squibb. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procter Gamble and Bristol-Myers Squibb.

Diversification Opportunities for Procter Gamble and Bristol-Myers Squibb

-0.39

Correlation Coefficient

Procter Gamble  Bristol-Myers Squibb

Very good diversification

The 3 months correlation between Procter and Bristol-Myers is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Procter Gamble and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Procter Gamble is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procter Gamble are associated (or correlated) with Bristol-Myers Squibb. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Procter Gamble i.e., Procter Gamble and Bristol-Myers Squibb go up and down completely randomly.

Pair Corralation between Procter Gamble and Bristol-Myers Squibb

Allowing for the 90-day total investment horizon Procter Gamble is expected to generate 9.96 times less return on investment than Bristol-Myers Squibb. But when comparing it to its historical volatility, Procter Gamble is 4.02 times less risky than Bristol-Myers Squibb. It trades about 0.02 of its potential returns per unit of risk. Bristol Myers Squibb is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  72,000  in Bristol Myers Squibb on August 12, 2024 and sell it today you would earn a total of  12,500  from holding Bristol Myers Squibb or generate 17.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.1%
Values	Daily Returns

Procter Gamble  vs.  Bristol Myers Squibb

Procter Gamble

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Procter Gamble are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Procter Gamble is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Bristol Myers Squibb

Risk-Adjusted Performance

4 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol-Myers Squibb may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Procter Gamble and Bristol-Myers Squibb

The main advantage of trading using opposite Procter Gamble and Bristol-Myers Squibb positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procter Gamble position performs unexpectedly, Bristol-Myers Squibb can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol-Myers Squibb will offset losses from the drop in Bristol-Myers Squibb's long position.

The idea behind Procter Gamble and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.